Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Dassault Systèmes SE    DSY   FR0000130650

DASSAULT SYSTÈMES SE

(DSY)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Dassault Systemes : targets life sciences with $5.8 billion Medidata deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/12/2019 | 04:33am EDT
Dassault Systemes CEO Bernard Charles attends the Reuters Global Technology Summit in Paris

PARIS (Reuters) - France's Dassault Systemes moved to build up its life sciences presence with a $5.8 billion (£4.7 billion) cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials.

By Sudip Kar-Gupta and Gwénaëlle Barzic

Dassault Systemes has been doing deals to diversify its technology and software businesses further and its agreed acquisition of Medidata, its largest, follows its purchases of companies including Trace Software and Argosim.

Medidata has a market capitalisation of around $5.9 billion, Refinitiv Eikon data shows, while Dassault has a stock market value of around 36 billion euros ($41 billion).

Although the $92.25 per share offered marked a slight discount to Medidata's closing price of $94.75 on June 11, analysts said that it was at a premium of 6.6% to Medidata's 50-day average price of $86.50 over the last 50 days.

Medidata's shares had also risen 5.5% to around $100 in after-hours trading on Tuesday, on growing speculation of a takeover by Dassault Systemes.

The French company added the Medidata takeover, which it said has a $5.8 billion enterprise value, would strengthen its position in life sciences and boost earnings from 2020 onwards.

"Multidiscipline scientific innovation and industrial performance call for a platform approach connecting the dots between people, ideas and data," said Bernard Charlès, Vice Chairman and CEO of Dassault Systèmes.

Deloitte this year forecast strong growth in the life sciences industry, saying it would benefit from a general rise in spending on healthcare, which in turn would necessitate more spending on technology. (https://bit.ly/2evoaRZ)

France's Dassault family has stakes in both Dassault Systèmes and the aerospace-focused Dassault Aviation company, but the two are separate entities.

Dassault Systeme's finance director, Pascal Daloz, said the French company had also signed a debt financing deal worth around 4 billion euros to fund its purchase of Medidata.

Invest Securities said the size of the deal had taken some investors by surprise, but Roche Brune Asset Management fund manager Gregoire Laverne said it was seen as a positive step.

"Dassault Systemes nevertheless has a big enough balance sheet to able to finance part of the acquisition," said Laverne, whose firms owns Dassault shares.

Medidata had 2018 revenue of $636 million, and Dassault Systemes expects to close the deal in the fourth quarter.

(Reporting by Sudip Kar-Gupta; Editing by Muralikumar Anantharaman, Gopakumar Warrier and Alexander Smith)

By Sudip Kar-Gupta and Gwénaëlle Barzic

Stocks mentioned in the article
ChangeLast1st jan.
DASSAULT SYSTÈMES SE -1.20% 136.1 Real-time Quote.31.24%
MEDIDATA SOLUTIONS, INC. -0.10% 91.87 Delayed Quote.36.27%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DASSAULT SYSTÈMES SE
10/15Time running out to get off Amazon's addictive cloud French minister warns
RE
10/10DASSAULT SYSTEMES : Systèmes to publish its Third Quarter 2019 reults, webcast a..
GL
10/03France recruits Dassault Systemes, OVH for alternative to U.S. cloud firms
RE
09/24DASSAULT SYSTEMES : Systèmes announces extension of CFIUS review process for pla..
PU
09/24DASSAULT SYSTEMES : Systèmes announces extension of CFIUS review process for pla..
GL
09/10DASSAULT SYSTÈMES : Dassault Systèmes successfully prices €3.65 billion bonds
GL
09/06DASSAULT SYSTEMES : Siemens and Dassault Systemes take Top Spots in ABI Research..
AQ
09/05KKR to sell or float German defence supplier Hensoldt - sources
RE
08/27DASSAULT SYSTEMES : Systèmes assigned a rating of A- / Stable by S&P Global Rati..
GL
08/19DASSAULT SYSTEMES : Systèmes Announces Medidata Stockholder Approval for Planned..
AQ
More news
Financials (EUR)
Sales 2019 3 970 M
EBIT 2019 1 297 M
Net income 2019 683 M
Finance 2019 2 180 M
Yield 2019 0,54%
P/E ratio 2019 51,0x
P/E ratio 2020 44,2x
EV / Sales2019 8,35x
EV / Sales2020 7,45x
Capitalization 35 342 M
Chart DASSAULT SYSTÈMES SE
Duration : Period :
Dassault Systèmes SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DASSAULT SYSTÈMES SE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 141,34  €
Last Close Price 136,10  €
Spread / Highest target 24,9%
Spread / Average Target 3,85%
Spread / Lowest Target -30,2%
EPS Revisions
Managers
NameTitle
Bernard Charlès Vice Chairman & Chief Executive Officer
Charles Edelstenne Chairman
Pascal Daloz Chief Financial Officer, EVP & Head-Strategy
Dominique Florack President-Research & Development
Laurence Barthès Executive VP, Chief People & Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
DASSAULT SYSTÈMES SE31.24%39 370
ACCENTURE32.67%119 196
INTERNATIONAL BUSINESS MACHINES CORPORATION17.96%118 787
TATA CONSULTANCY SERVICES7.28%108 615
AUTOMATIC DATA PROCESSING24.73%70 927
VMWARE, INC.10.95%62 169